A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study

Detalles Bibliográficos
Autores principales: Popat, Uday R., Andersson, Borje S., Bassett, Roland, Kawedia, Jitesh, Valdez, Ben C., Alousi, Amin M., Al-Atrash, Gheath, Bashir, Qaiser, Hosing, Chitra M., Im, Jin S., Kebriaei, Partow, Marin, David, Nieto, Yago, Oran, Betul, Olson, Amanda, Qazilbash, Muzaffar H., Srour, Samer A., Shpall, Elizabeth J., Champlin, Richard E., Mehta, Rohtesh S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521225/
https://www.ncbi.nlm.nih.gov/pubmed/35770531
http://dx.doi.org/10.3324/haematol.2022.280778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521225/
https://www.ncbi.nlm.nih.gov/pubmed/35770531
http://dx.doi.org/10.3324/haematol.2022.280778

Ejemplares similares